Style | Citing Format |
---|---|
MLA | Sharifinejad N, et al.. "First Patient in the Iranian Registry With Novel Dock2 Gene Mutation, Presenting With Skeletal Tuberculosis, and Review of Literature." Allergy# Asthma and Clinical Immunology, vol. 17, no. 1, 2021, pp. -. |
APA | Sharifinejad N, Sadri H, Kalantari A, Delavari S, Noohi A, Aminpour Y, Sabzevari A, Azizi G (2021). First Patient in the Iranian Registry With Novel Dock2 Gene Mutation, Presenting With Skeletal Tuberculosis, and Review of Literature. Allergy# Asthma and Clinical Immunology, 17(1), -. |
Chicago | Sharifinejad N, Sadri H, Kalantari A, Delavari S, Noohi A, Aminpour Y, Sabzevari A, Azizi G. "First Patient in the Iranian Registry With Novel Dock2 Gene Mutation, Presenting With Skeletal Tuberculosis, and Review of Literature." Allergy# Asthma and Clinical Immunology 17, no. 1 (2021): -. |
Harvard | Sharifinejad N et al. (2021) 'First Patient in the Iranian Registry With Novel Dock2 Gene Mutation, Presenting With Skeletal Tuberculosis, and Review of Literature', Allergy# Asthma and Clinical Immunology, 17(1), pp. -. |
Vancouver | Sharifinejad N, Sadri H, Kalantari A, Delavari S, Noohi A, Aminpour Y, et al.. First Patient in the Iranian Registry With Novel Dock2 Gene Mutation, Presenting With Skeletal Tuberculosis, and Review of Literature. Allergy# Asthma and Clinical Immunology. 2021;17(1):-. |
BibTex | @article{ author = {Sharifinejad N and Sadri H and Kalantari A and Delavari S and Noohi A and Aminpour Y and Sabzevari A and Azizi G}, title = {First Patient in the Iranian Registry With Novel Dock2 Gene Mutation, Presenting With Skeletal Tuberculosis, and Review of Literature}, journal = {Allergy# Asthma and Clinical Immunology}, volume = {17}, number = {1}, pages = {-}, year = {2021} } |
RIS | TY - JOUR AU - Sharifinejad N AU - Sadri H AU - Kalantari A AU - Delavari S AU - Noohi A AU - Aminpour Y AU - Sabzevari A AU - Azizi G TI - First Patient in the Iranian Registry With Novel Dock2 Gene Mutation, Presenting With Skeletal Tuberculosis, and Review of Literature JO - Allergy# Asthma and Clinical Immunology VL - 17 IS - 1 SP - EP - PY - 2021 ER - |